Israel Englander, the co-founder and CEO of Millennium Management, has spent nearly four decades building one of the most sophisticated and resilient engines in the hedge fund world. As of April 2026, his fund manages a staggering $237 billion in the 13F portfolio, operating on a multi-manager platform that prioritizes risk mitigation over directional bets. The top holdings in the portfolio are concentrated in the technology and financial services sectors. Englander’s investment style is defined by its lack of sentimentality. Unlike traditional stock-pickers who fall in love with a company’s vision, Englander oversees more than 330 independent pods—trading teams that operate across equities, fixed income, and commodities.
READ MORE: 15 Best Stocks to Buy According to Billionaire Ray Dalio.
Englander’s success is rooted in his meritocratic and non-directional philosophy. In a rare public reflection, through an annual investor letter, he has previously noted that what his fund had built was larger than any one person and was designed to endure and thrive. This endurance is enforced by a ruthless risk management system often referred to as the Kill Switch. If a trading pod loses approximately 5% of its capital, its allocation is halved; a 7.5% loss results in the immediate dissolution of the team. This survival of the fittest model allowed Millennium to deliver a 10.5% return in 2025, successfully navigating the early-year volatility of the US trade wars.
READ MORE: 10 Best Stocks to Buy According to Billionaire Paul Tudor Jones.
Israel Englander of Millennium Management
Our Methodology
To compile our list of the best stocks to buy according to billionaire Israel Englander, we reviewed the latest 13F filings of Millennium Management. Next, we focused on the top 10 stocks in his portfolio. Data for the hedge fund sentiment surrounding each stock was taken from Insider Monkey’s Q4 2025 database of 1041 elite hedge funds.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 498.7% since May 2014, beating its benchmark by 303 percentage points (see more details here).
Israel Englander Stock Portfolio: Top Stock Picks
10. Freeport-McMoRan Inc. (NYSE:FCX)
Millennium Management’s Stake: $809 Million
Freeport-McMoRan Inc. (NYSE:FCX) has been a staple in the 13F portfolio of Millennium Management for more than a decade and a half. The fund first disclosed a stake in the company back in the fourth quarter of 2010. This holding comprised 111,000 shares. In the coming years, it steadily increased, reaching nearly 8 million shares in early 2018. A trimming period followed and by late 2019, the position had been reduced to almost 270,000 shares. The fund then started buying the stock again. Filings for the fourth quarter of 2025 show that the fund owns nearly 16 million shares in the firm, up almost 30% compared to filings for the previous quarter.
Hedge fund interest in Freeport-McMoRan Inc. (NYSE:FCX) has increased in recent months as the firm offers exposure to two high-performing commodities simultaneously. As the world’s largest publicly traded copper producer, FCX is the primary vehicle for hedge funds to bet on the global electrification trend. In 2026, the demand narrative has shifted beyond just EVs to include the massive power requirements of AI data centers and grid-scale battery storage. Unlike pure-play copper miners, FCX’s Grasberg mine in Indonesia is a powerhouse for gold. Hedge funds are using FCX as a geopolitical hedge, as gold prices have remained strong amid global currency volatility.
9. Amazon.com, Inc. (NASDAQ:AMZN)
Millennium Management’s Stake: $838 Million
Amazon.com, Inc. (NASDAQ:AMZN) is another long-term bet of Israel Englander. His fund first disclosed a stake in the tech giant back in the fourth quarter of 2010. Back then, this holding comprised nearly 700,000 shares. The fund continued building on this stake and increased share ownership in the firm to 16.3 million shares by the third quarter of 2015. Thereafter, this position was trimmed and eventually sold off. A new position was then opened in the third quarter of 2017. The stock has consistently appeared in the 13F portfolio of the fund since then. Filings for the fourth quarter of 2025 show that the fund owned 3.6 million shares in the firm, down 3% compared to filings for the previous quarter.
Amazon.com, Inc. (NASDAQ:AMZN) has spent aggressively on AI and hedge funds are betting on these investments bearing fruit in the coming months. After a period of slower growth, Amazon Web Services (AWS) revenue growth accelerated to 24% in Q4 2025. Institutional investors are also tracking AWS’s record $244 billion backlog, up 40% year-over-year. Funds are rewarding Amazon’s vertical integration as well. Its custom AI chips, Trainium and Graviton, are now a $10 billion+ annualized business, growing at triple-digit rates. This reduces dependency on expensive Nvidia hardware and expands margins.
8. Alphabet Inc. (NASDAQ:GOOGL)
Millennium Management’s Stake: $840 Million
Alphabet Inc. (NASDAQ:GOOGL) has consistently appeared in the 13F portfolio of Millennium Management since the third quarter of 2015. Back then, this stake comprised 7.2 million shares. Apart from the fourth quarter of 2020, this holding has remained below this figure in all filings submitted since then. The holding even dropped to 366,000 shares in the second quarter of 2022. Filings for the fourth quarter of 2025 show that the fund owned 2.7 million shares in the tech giant, down nearly 26% compared to filings for the third quarter of 2025.
Alphabet Inc. (NASDAQ:GOOGL) is one of the favorite mega tech stocks on Wall Street because even with the 2026 stock rally, it remains one of the most reasonably priced Magnificent Seven stocks. Trading at less than 30x forward earnings, it is significantly cheaper than peers like Microsoft or Amazon. Hedge funds view the core search monopoly as a cash cow that provides a safety floor, allowing them to get the AI growth potential for a relatively lower entry price. Institutional investors are also rewarding Alphabet for its independence from the expensive Nvidia tax. The firm recently unveiled Ironwood, its latest custom AI chip. This chip allows Google to run AI workloads at a much lower cost than competitors who must buy off-the-shelf hardware.
7. Intuitive Surgical, Inc. (NASDAQ:ISRG)
Millennium Management’s Stake: $842 Million
Israel Englander has been a long-term admirer of Intuitive Surgical, Inc. (NASDAQ:ISRG) stock. The firm first made an appearance in the 13F portfolio of the fund in the fourth quarter of 2010. This holding comprised around 200,000 shares. After several buying sprees, this position was increased to nearly 3 million shares by the fourth quarter of 2014. A period of trimming followed and share ownership dropped down to 15,000 shares by the second quarter of 2020. The fund then started buying the stock again. Filings for the fourth quarter of 2025 show that the fund owned 1.5 million shares in the firm, up 470% compared to filings for the previous quarter.
A major reason hedge funds prefer Intuitive Surgical, Inc. (NASDAQ:ISRG) over other medical device companies is its razor-and-blade business model. As of April 2026, 81% of Intuitive’s revenue is recurring, coming from service contracts and high-margin Instruments & Accessories. Overall procedure volume grew 18% in 2025, reaching 3.1 million procedures. Hedge funds love this metric because every surgery performed generates immediate high-margin revenue through the consumption of single-use surgical tools. Beyond the core multi-port system, hedge funds are betting on the diversification of Intuitive’s platform. Ion procedure volume grew by 44% in late 2025. This allows the company to dominate the early-stage lung cancer diagnostics market.
6. Microsoft Corporation (NASDAQ:MSFT)
Millennium Management’s Stake: $1.1 Billion
Microsoft Corporation (NASDAQ:MSFT) represents another long-term bet of Israel Englander. His fund first purchased a stake in the company back in the fourth quarter of 2010. This position comprised 250,000 shares. This holding remained relatively constant for years, before the fund went on a buying spree and increased it to 4.4 million shares in late 2014. By the fourth quarter of 2020. Millennium Management had grown this holding to more than 8 million shares. Thereafter, the position was trimmed and dropped to around 788,000 shares by the middle of 2021. Filings for the fourth quarter of 2025 show that the fund owned 2.3 million shares in the firm, down 33% compared to filings for the previous quarter.
Microsoft Corporation (NASDAQ:MSFT) stock has had a rough year but hedge funds remain bullish on the long-term prospects of the firm. Microsoft’s 30% drawdown in early 2026, its worst since 2008, has reset its valuation to roughly 22x forward earnings. This is well below its 10-year average, leading value-oriented hedge funds to aggressively add to their positions. Hedge funds are betting that Microsoft is moving past the AI experimentation phase into full-scale deployment. In early 2026, Microsoft inked massive strategic partnerships with IT giants like Cognizant, Infosys, TCS, and Wipro to deploy 50,000 Copilot licenses. Analysts expect upcoming price hikes for Microsoft 365 – scheduled for July 2026 – and new Agentic AI features to add between $2 billion and $6 billion in incremental revenue by 2027.
While we acknowledge the potential of MSFT to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than MSFT and that has 100x upside potential, check out our report about the cheapest AI stock.
Click to continue reading and see Israel Englander Stock Portfolio: Top 5 Stocks Picks.
READ NEXT: D. E. Shaw Stock Portfolio: Top 10 Stocks to Buy and 10 Best Stocks to Buy According to Billionaire Rob Citrone.
Disclosure: None. Follow Insider Monkey on Google News.
